Olivier Ballevre

This inventor holds 20 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents, primarily in Nutritional Composition. Top assignees: Nestec S.a., L'oreal. Active years: 1998-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Ballevre. Retrieved from https://idiyas.com/inventor/olivier-ballevre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20

% Patents Active = 70.0

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.9

ph-index = 11

Forward Citations = 337(Granted Patents)

Location History:

Lausanne 25, CH (2012)
Lausanne, CH (1998 - 2013)
Beijing, CN (2015)

Company Filing History:

where one patent can have more than one assignee

Years Active: 1998-2015

Loading Chart...

Areas of Expertise:

Wolfberries

Amino Acids

Glutamine

Nutritional Modules

Irritable Bowel Syndrome

Infant Formula

Probiotics

Protein Digestion

Food Viscosity

Casein Protein

Whey Protein

Gastro-Intestinal Maturation

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9072769 - Wolfberries and skin inflammation (2015-07-07),

2. 8383680 - Composition comprising free amino acids (2013-02-26),

3. 8178487 - Method for providing glutamine (2012-05-15),

4. 8067471 - Composition comprising free amino acids (2011-11-29),

5. 7794744 - Nutritional modules (2010-09-14),

6. 7776332 - Composition comprising casein protein and whey protein (2010-08-17),

7. 7666830 - Nutritional composition preventing bacterial overgrowth (2010-02-23),

8. 7320810 - Food product with high viscosity (2008-01-22),

9. 7141554 - Method of treating irritable bowel syndrome (2006-11-28),

10. 6833350 - Method for maintaining or improving the synthesis of mucins (2004-12-21),

11. 6777391 - Composition for an infant formula having a low threonine content (2004-08-17),

12. 6733770 - Nutritional composition intended for specific gastro-intestinal maturation in premature mammals (2004-05-11),

13. 6596332 - Gelatinized cereal product containing oligosaccharide (2003-07-22),

14. 6544515 - Acceleration of the rate of digestion of a protein (2003-04-08),

15. 6506422 - Nutritional formula for phenylketonuria patients (2003-01-14),

Title: Olivier Ballevre: Innovator in Inflammation Treatment

Introduction

Olivier Ballevre, a distinguished inventor based in Lausanne, Switzerland, has made significant contributions to the field of health and wellness. With a remarkable portfolio of 20 patents, his innovations focus on natural remedies and their applications in treating various health concerns, particularly inflammation.

Latest Patents

Among his latest inventions is a patent that addresses skin inflammation through the use of wolfberries. This invention highlights the utilization of natural compounds to create products designed to treat or prevent inflammation. Research indicates that extracts of wolfberries possess anti-inflammatory properties, and Ballevre's invention showcases a primary composition comprising these berries.

Additionally, he has developed a method for the prevention and treatment of patients with impaired gastrointestinal tract function. This method involves administering free amino acids, specifically containing 9.0% to 17.0% glutamic acid, to enhance patient care and improve health outcomes.

Career Highlights

Olivier Ballevre has held positions in reputable companies, including Nestec S.A. and L'Oréal, where he has applied his expertise in advancing product innovation and development. His work has not only contributed to the companies' portfolios but also enriched the field of health-related inventions.

Collaborations

Throughout his career, Ballevre has collaborated with esteemed professionals in the industry, including Florence Rochat and Julio Boza. These partnerships have fostered a collaborative environment that emphasizes innovation and efficiency in research and development.

Conclusion

Olivier Ballevre stands as a notable figure in the realm of inventions related to inflammation treatment. His latest patents demonstrate a commitment to employing natural compounds to address health issues, further establishing his legacy as an influential inventor in the health sector. With continued contributions, Ballevre is poised to make even more significant impacts on healthcare and wellness solutions.

Profile summary based on public USPTO records.